Precision Theranostics in Nuclear Medicine Targeting Gastrin-Releasing Peptide Receptor
The gastrin-releasing peptide receptor (GRPR) is highly expressed in various malignant tumors (e.g., glioblastoma, prostate cancer, and breast cancer) and has emerged as an important molecular target for precision cancer diagnosis and therapy. In recent years, the combined application of radionuclid...
Wedi'i Gadw mewn:
| Prif Awduron: | , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Chinês |
| Cyhoeddwyd: |
Editorial Office of Medical Journal of Peking Union Medical College Hospital
2025-07-01
|
| Cyfres: | Xiehe Yixue Zazhi |
| Pynciau: | |
| Mynediad Ar-lein: | https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2025-0479 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|